FDA sharpens import inspection tools

Under its Analytical Tools Initiative, the FDA is training import personnel to use a hand-held device for detecting counterfeit drugs and packaging. The regulator is also training staff on a portable X-ray fluorescence device capable of detecting toxic elements. Report

Suggested Articles

Fujifilm Diosynth Biotechnologies last year committed 10 billion yen toward its manufacturing operations. It has now kicked off one of those projects.

Popular logic says you never switch horses, or CDMOs, in the middle of the stream, but Acacia Pharma had to do that to win an FDA approval.

The FDA has found issues with the testing practices of a U.S. generics maker that had specific problems with ADHD and weight-loss drugs.